Consultation for the proposed quality standards for MDMA and psilocybin

While the consultation is open you can make a submission at our consultation hub.

We review the submissions. After that the submissions will be available on the same consultation page. 

About this consultation

We have developed two new quality standards for MDMA and psilocybin that will be registered as legislative instruments on the Federal Register of Legislation in Australia as Therapeutic Goods Orders (TGOs).

We are undertaking public consultation to seek feedback from patients, psychiatrists, health practitioners, pharmacists, manufacturers, and other interested stakeholders on the appropriateness of the proposed requirements in the draft TGOs. 

All recent consultations can be found on our TGA Consultation hub.